Tate & Lyle PLC (OTCMKTS:TATYY – Get Free Report) was the recipient of a large drop in short interest in the month of August. As of August 14th, there was short interest totaling 105 shares, a drop of 41.7% from the July 30th total of 180 shares. Based on an average trading volume of 822 shares, the short-interest ratio is presently 0.1 days. Approximately 0.0% of the company’s shares are sold short.
Tate & Lyle Price Performance
OTCMKTS:TATYY opened at $30.02 on Wednesday. Tate & Lyle has a 12 month low of $17.64 and a 12 month high of $30.50. The company has a debt-to-equity ratio of 0.80, a quick ratio of 1.55 and a current ratio of 2.71. The firm has a fifty day simple moving average of $29.85 and a two-hundred day simple moving average of $25.05.
Analyst Ratings Changes
A number of brokerages have recently issued reports on TATYY. BNP Paribas Exane downgraded Tate & Lyle to a “neutral” rating in a research note on Tuesday, June 9th. Deutsche Bank Aktiengesellschaft cut Tate & Lyle from a “buy” rating to a “hold” rating in a research note on Friday, June 26th. Four analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Reduce”.
Tate & Lyle Company Profile
Tate & Lyle (OTCMKTS:TATYY) is a global provider of food and beverage ingredients, specializing in sweeteners, texturants and stabilizers. The company develops and supplies a diverse portfolio of products designed to enhance taste, texture and nutritional value for food and beverage manufacturers. Key offerings include high-intensity sweeteners, soluble and insoluble fibers, specialty starches and acidulants.
Operating through two main business units—Food & Beverage Solutions and Primary Products—Tate & Lyle serves a wide range of end markets.
See Also
- Five stocks we like better than Tate & Lyle
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Receive News & Ratings for Tate & Lyle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tate & Lyle and related companies with MarketBeat.com's FREE daily email newsletter.
